Richard Paul Cambria, MD, is a vascular surgeon at the Massachusetts General Hospital Vascular Center.
- Centers & Specialties
- Clinical Interests
- Renovascular and Carotid Disease
- Thoracic / Thoracoabdominal aneurysm repair
- Vascular / Endovascular surgery
- Medical Education
- MD, Columbia University College of Physicians and Surgeons
- Residency, Massachusetts General Hospital
- Board Certifications
- Vascular Surgery
- Boston: Massachusetts General Hospital
- Waltham: Mass General West
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Harvard Pilgrim Health Plan - SSN
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
Richard P. Cambria, M.D. is Professor of Surgery at Harvard Medical School and Chief, Division of Vascular/Endovascular Surgery at Massachusetts General Hospital. Dr. Cambria received his medical degree from the College of Physicians and Surgeons, Columbia University, in 1977. He trained in general and vascular surgery at Massachusetts General Hospital. After a brief stint on the faculty at Yale, Dr. Cambria returned to MGH as Associate Professor of Surgery in 1986. He was promoted to Professor of Surgery in 2001 and Chief of the reformed Division of Vascular and Endovascular Surgery in 2002. He took advanced training in endovascular catheter-based therapies at Cleveland Clinic.
Dr. Cambria's clinical, professional and academic interests are principally in the area of diseases of the aorta and its branches. He is a nationally and internationally known expert in the treatment of complex aneurysm disease. According to the Massachusetts State website, he has the largest practice of both aneurysm and carotid artery surgery in the State. He currently leads a division that has performed more stent graft repairs of both abdominal and thoracic aortic aneurysms than any institution in the Northeast. He founded and is co-director of the Thoracic Aortic Center at MGH beginning in 1999. He is a Past President of both the NESVS and the Society for Vascular Surgery. He is Associate Editor of The Journal of Vascular Surgery and his curriculum vitae details more than 275 peer-reviewed publications and book chapters.
Cambria RP. The endovascular revolution stopped at the carotid bifurcation . . . or did it? J Vasc Surgery 2012; 56:1748-60.
Patterson B, Holt P, Neinaber C, Cambria R, Fairman R, Thompson M. Aortic Pathology Determines Midterm Outcome After Endovascular Repair of the Thoracic Aorta: Report from the Medtronic Thoracic Endovascular Registry (MOTHER) Database. Circulation 2013;127:24-32.
Abbott AL, Adelman MA, Alexandrov AV, Barber PA, Barnett HJ, Beard J, Cambria RP, et al. Why Calls for More Routine Carotid Stenting Are Currently Inappropriate: An International, Multispecialty, Expert Review and Position Statement. Stroke 2013; 44(4): 1186-90.
Conrad MF, Baloum V, Mukhopadhyay S, Garg A, Pater VI, Cambria RP. Progression of asymptomatic carotid stenosis despite optimal medical therapy. J Vasc Surgery 2013; 58:128-135.
Lancaster RL, Conrad MF, Patel VI, Cambria MR, Ergul EA, Cambria RP. Further experience with distal aortic perfusion and motor-evoked potential monitoring in the management of extent I-III thoracoabdominal aneurysms. J Vasc Surgery 2013; 58:283-290.
Massachusetts General Hospital now offering less-invasive procedure for treatment of carotid artery disease
Physicians in the Fireman Vascular Center at Massachusetts General Hospital (MGH) are now offering a new and less invasive method of treatment for carotid artery disease known as transcarotid artery revascularization, or TCAR.
Researchers at Massachusetts General Hospital have conducted evaluations of thoracic endovascular aortic aneurysm repair (TEVAR) for a variety of aortic pathologies—investigating the short-term safety and efficacy as well as long-term durability of this technique.
Richard Cambria, MD, chief of the MGH Division of Vascular and Endovascular Surgery and co-director of the Thoracic Aortic Center, is the first incumbent to the Robert R. Linton, MD, Professorship in Surgery in the Field of Vascular and Endovascular Surgery at Harvard Medical School.
Hotline - "In General" Awards and Honors: Richard Cambria, MD, chief of the Division of Vascular and Endovascular Surgery and co-director of the Thoracic Aortic Center, was elected 2011-2012 president of the Society for Vascular Surgery (SVS) on June 17 during the Vascular Annual Meeting in Chicago. ----- Daniel Kopans, MD, founder of the MGH Breast Imaging Division, received a special commendation from the Society of Breast Imaging (SBI) and a standing ovation from the more than 800 attendees at its annual meeting in recognition of his dedication and leadership in mammography screening.
Richard P. Cambria, MD, is the fourth Mass General surgeon to lead the Society for Vascular Surgery, the largest medical society of vascular surgeons.
Investigators from Massachusetts General Hospital revealed the results of the CREST trial, a study that looked at the efficacy of carotid endarterectomy versus stenting in patients with symptomatic carotid stenosis, and found that these two medical procedures are both equally safe and effective.
Dr. Richard Cambria, chief of vascular surgery at Mass General, says family history can provide clues
Dr. Richard Cambria, chief of vascular surgery at Mass General, says family history can provide clues.
15 Parkman Street
Boston MA, 02114-3117
Phone 1: 617-726-8279